WallStSmart
APYX

Apyx Medical Inc

NASDAQ: APYX · HEALTHCARE · MEDICAL DEVICES

$3.46
-5.72% today

Updated 2026-04-29

Market cap
$144.73M
P/E ratio
P/S ratio
2.74x
EPS (TTM)
$-0.27
Dividend yield
52W range
$1 – $5
Volume
0.1M

Apyx Medical Inc (APYX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+78.7%
Last 4 quarters
Revenue YoY growth
+34.7%
Most recent quarter
EPS YoY growth
+75.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+18.9%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+23.2%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.03+46.4%$3.43$3.93+14.6%
2025-11-06$-0.05+51.6%$3.14$3.87+23.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.06$-0.03+46.4%$19.16M+34.7%
2025-09-30$-0.10$-0.05+51.6%$12.88M+12.1%
2025-06-30$-0.09$0.09+200.0%$11.37M-6.4%
2025-03-31$-0.12$-0.10+16.7%$9.43M-7.9%
2024-12-31$-0.16$-0.12+25.0%$14.22M-3.0%
2024-09-30$-0.19$-0.14+26.3%$11.49M-4.1%
2024-06-30$-0.20$-0.19+5.0%$12.15M-10.5%
2024-03-31$-0.21$-0.22-4.8%$10.24M-15.6%
2023-12-31$-0.18$-0.28-55.6%$14.66M
2023-09-30$-0.11$-0.13-18.2%$11.98M
2023-06-30$-0.07$-0.11-57.1%$13.57M
2023-03-31$-0.13$-0.10+23.1%$12.14M

Frequently asked questions

Has Apyx Medical Inc beaten earnings estimates?
Apyx Medical Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +78.7% over the last 4 quarters.
How does APYX stock react to earnings?
APYX stock has moved an average of +18.9% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Apyx Medical Inc's revenue growth rate?
Apyx Medical Inc reported year-over-year revenue growth of +34.7% in its most recent quarter, with EPS growing +75.0% year-over-year.